Skip Navigation LinksSkip Navigation Links
Centers for Disease Control and Prevention
Safer Healthier People
Blue White
Blue White
bottom curve
CDC Home Search Health Topics A-Z spacer spacer
spacer
Blue curve MMWR spacer
spacer
spacer

The content, links, and pdfs are no longer maintained and might be outdated.

  • The content on this page is being archived for historic and reference purposes only.
  • For current, updated information see the MMWR website.

Appendix Waiver Letters from Physicians

A physician's letter stating the contraindication to vaccination has been acceptable to certain governments outside the United States. Ideally, the letter should be written on letterhead stationary and bear the stamp used by health department and official vaccination centers to validate the International Certificate of Vaccination. When planning to use a waiver letter, the traveler should also obtain specific and authoritative advice from the embassy or consulate of the country or countries she or he plans to visit. Waivers of requirements obtained from embassies or consulates should be documented by appropriate letters and retained for presentation with the International Health Certificate.

Advisory Committee on Immunization Practices
Membership List, February 2002

Chairman: John F. Modlin, M.D., Professor of Pediatrics and Medicine, Dartmouth Medical School, Lebanon, New Hampshire.
Executive Secretary: Dixie E. Snider, Jr., M.D., Associate Director for Science, Centers for Disease Control and Prevention, Atlanta, Georgia.
Members: Robert B. Belshe, M.D., Saint Louis University Health Sciences Center, St. Louis, Missouri; Guthrie S. Birkhead, M.D., New York State Department of Health, Albany, New York; Dennis A. Brooks, M.D., Johnson Medical Center, Baltimore, Maryland; Jaime Deseda-Tous, M.D., San Jorge Children's Hospital, San Juan, Puerto Rico; Celine I. Hanson, M.D., Texas Department of Health, Austin, Texas; Paul A. Offit, M.D., Children's Hospital of Philadelphia, Philadelphia, Pennsylvania; Margaret B. Rennels, M.D., University of Maryland School of Medicine, Baltimore, Maryland; John E. Salamone, Washington, D.C.; Natalie J. Smith, M.D., California Department of Health Services, Berkeley, California; Lucy S. Tompkins, M.D., Ph.D., Stanford University Medical Center, Stanford, California; Bonnie M. Word, M.D., Monmouth Junction, New Jersey; and Richard Zimmerman, M.D., University of Pittsburgh School of Medicine, Pittsburgh, Pennsylvania.
Ex-Officio Members: James Cheek, M.D., Indian Health Service, Albuquerque, New Mexico; Col. Benedict M. Diniega, M.D., Department of Defense, Falls Church, Virginia; Geoffrey S. Evans, M.D., Health Resources and Services Administration, Rockville, Maryland; T. Randolph Graydon, Centers for Medicare and Medicaid Services, Baltimore, Maryland; Carole Heilman, Ph.D., National Institutes of Health, Bethesda, Maryland; Karen Midthun, M.D., Food and Drug Administration, Bethesda, Maryland; Eve Slater, M.D., National Vaccine Program Office, CDC, Atlanta, Georgia; and Kristin Lee Nichol, M.D., Veterans Administration Medical Center, Minneapolis, Minnesota.
Liaison Representatives: American Academy of Family Physicians, Richard D. Clover, M.D., Louisville, Kentucky, and Martin Mahoney, M.D., Ph.D., Clarence, New York; American Academy of Pediatrics, Jon Abramson, M.D., Winston-Salem, North Carolina, and Gary Overturf, M.D., Albuquerque, New Mexico; American Association of Health Plans, Eric K. France, M.D., Denver, Colorado; American College of Obstetricians and Gynecologists, Stanley A. Gall, M.D., Louisville, Kentucky; American College of Physicians, Kathleen M. Neuzil, M.D., Seattle, Washington; American Medical Association, H. David Wilson, M.D., Grand Forks, North Dakota; American Pharmaceutical Association, Stephan L. Foster, Pharm.D., Memphis, Tennessee; Association of Teachers of Preventive Medicine, W. Paul McKinney, M.D., Louisville, Kentucky; Canadian National Advisory Committee on Immunization, Victor Marchessault, M.D., Cumberland, Ontario, Canada; Healthcare Infection Control Practices Advisory Committee, Jane D. Siegel, M.D., Dallas, Texas; Infectious Diseases Society of America, Samuel L. Katz, M.D., Durham, North Carolina, and William Schaffner, M.D., Nashville, Tennessee; London Department of Health, David M. Salisbury, M.D., London, United Kingdom; National Coalition for Adult Immunization, David A. Neumann, Ph.D., Bethesda, Maryland; National Immunization Council and Child Health Program, Mexico, Jose Ignacio Santos, M.D., Mexico City, Mexico; National Medical Association, Rudolph E. Jackson, M.D., Atlanta, Georgia; National Vaccine Advisory Committee, Georges Peter, M.D., Providence, Rhode Island; and Pharmaceutical Research and Manufacturers of America, Kevin Reilly, Radnor, Pennsylvania.

Members of the Yellow Fever Working Group

Martin Cetron, M.D., Anthony A. Marfin, M.D., Kathleen G. Julian, M.D., Duane J. Gubler, Sc.D., Donald Sharp, M.D., Rachel S. Barwick. Ph.D., Leisa H. Weld, Ph.D., and Robert Chen, M.D., CDC, Atlanta, Georgia; Richard Clover, M.D., American Academy of Family Physicians, Louisville, Kentucky; Jaime Deseda-Tous, M.D., San Jorge Children's Hospital, San Juan, Puerto Rico; Victor Marchessault, M.D., Canadian National Advisory Committee on Immunization, Cumberland, Ontario, Canada; Karen Midthun, M.D., and Lewis Markoff, M.D., Food and Drug Administration, Bethesda, Maryland; and Paul A. Offit, M.D., Children's Hospital of Philadelphia, Philadelphia, Pennsylvania.

Consultants to the Yellow Fever Working Group

Dirk Teuwen, M.D., Aventis Pasteur, Inc., Swiftwater, Pennsylvania; and Thomas Monath, M.D., Acambis, Cambridge, England, United Kingdom.

Use of trade names and commercial sources is for identification only and does not imply endorsement by the U.S. Department of Health and Human Services.


References to non-CDC sites on the Internet are provided as a service to MMWR readers and do not constitute or imply endorsement of these organizations or their programs by CDC or the U.S. Department of Health and Human Services. CDC is not responsible for the content of pages found at these sites. URL addresses listed in MMWR were current as of the date of publication.

Disclaimer   All MMWR HTML versions of articles are electronic conversions from ASCII text into HTML. This conversion may have resulted in character translation or format errors in the HTML version. Users should not rely on this HTML document, but are referred to the electronic PDF version and/or the original MMWR paper copy for the official text, figures, and tables. An original paper copy of this issue can be obtained from the Superintendent of Documents, U.S. Government Printing Office (GPO), Washington, DC 20402-9371; telephone: (202) 512-1800. Contact GPO for current prices.

**Questions or messages regarding errors in formatting should be addressed to mmwrq@cdc.gov.

Page converted: 10/29/2002

HOME  |  ABOUT MMWR  |  MMWR SEARCH  |  DOWNLOADS  |  RSSCONTACT
POLICY  |  DISCLAIMER  |  ACCESSIBILITY

Safer, Healthier People

Morbidity and Mortality Weekly Report
Centers for Disease Control and Prevention
1600 Clifton Rd, MailStop E-90, Atlanta, GA 30333, U.S.A

USA.GovDHHS

Department of Health
and Human Services

This page last reviewed 10/29/2002